As part of its 50 years of excellence in medical research and innovation, the Centre de Recherche en Cancérologie de Marseille (CRCM) has published a special booklet that recounts its history and highlights key actors and essential collaborations.
Since its establishment 50 years ago, the CRCM has emerged as a pioneer in the field of cancer research, making significant contributions to scientific and medical advancements. This booklet allows us to retrace the significant moments that have marked the center’s journey, from its beginnings to its current position as a leader in the fight against cancer.
At the heart of this success is the close collaboration between the CRCM, the Institut Paoli-Calmettes (IPC), and the Assistance Publique – Hôpitaux de Marseille (AP-HM). The IPC, a reference center in oncology, and the AP-HM, one of the largest hospital establishments in France, have been essential partners in the realization of the CRCM’s scientific advancements.
The booklet also honors the four governing bodies of the CRCM: Inserm, CNRS, Aix-Marseille University (AMU), and IPC. Their unwavering support and commitment to research have created an environment conducive to innovation at the center. Their crucial role is highlighted, emphasizing the importance of their contribution to the ongoing success of the CRCM.
To mark the launch of this commemorative booklet, the CRCM wanted to express its deep gratitude to all those who have contributed to its history. Researchers, physicians, technical and administrative support staff, institutional partners, and all those who have supported the center over the decades have been instrumental in making the CRCM a world-renowned research institution. Their efforts and unwavering dedication deserve sincere recognition.
This anniversary booklet is an indispensable source of information to discover the history and accomplishments of the center, bearing witness to the determination and spirit of innovation that have driven this institution for 50 years.
With its wealth of experience, the CRCM looks towards the future with optimism, determined to continue its research and medical advancements to improve the lives of cancer patients, aiming to maintain the highest level of cancer research.